ECOR · electroCore Inc. Common Stock
View on chartInsiders & Stakes
| Errico Joseph P Director | ▲ Buy | Open Market | 2,724,841 Shares held | 12/13/2022 | View profile |
| Charles Steve Theofilos | ▲ Buy | Grant | 454,202 Shares held | 9/3/2024 | View profile |
| Thomas J. Errico Director | ▲ Buy | Open Market | 363,904 Shares held | 9/14/2026 | View profile |
| Daniel S. Goldberger Director | ▼ Sell | Open Market | 211,471 Shares held | 4/23/2026 | View profile |
| Joshua S. Lev Chief Financial Officer | ▲ Buy | Grant | 139,889 Shares held | 9/8/2026 | View profile |
| Michael Fox Chief Operating Officer | ▲ Buy | Grant | 130,000 Shares held | 9/11/2026 | View profile |
| Julie Ann Goldstein Director | ▲ Buy | Grant | 112,510 Shares held | 9/9/2026 | View profile |
| Thomas M. Patton Director | ▲ Buy | Grant | 102,782 Shares held | 9/2/2025 | View profile |
| John P. Gandolfo Director | ▲ Buy | Grant | 99,221 Shares held | 9/9/2026 | View profile |
| Patricia Wilber Director | ▲ Buy | Grant | 83,448 Shares held | 9/9/2026 | View profile |
| Moody Trevor J Director | ▲ Buy | Grant | 67,592 Shares held | 8/2/2023 | View profile |
| Elena Bonfiglioli Director | ▲ Buy | Grant | 41,672 Shares held | 9/9/2026 | View profile |
| James Charles Theofilos Director | ▲ Buy | Grant | 34,670 Shares held | 9/9/2026 | View profile |
| Brian M. Posner Chief Financial Officer | ▲ Buy | Open Market | 22,437 Shares held | 1/12/2024 | View profile |
| CUNEO F PETER Director | ▲ Buy | Grant | 5,665 Shares held | 8/2/2023 | View profile |
Transaction History
| Thomas J. Errico | ▲ Buy | Open Market | 5,000 | $49K | 9/14/2026 |
| Michael Fox | ▲ Buy | Grant | 5,000 | $49K | 9/11/2026 |
| Julie Ann Goldstein | ▲ Buy | Grant | 11,123 | $0 | 9/9/2026 |
| Thomas J. Errico | ▲ Buy | Grant | 15,572 | $0 | 9/9/2026 |
| John P. Gandolfo | ▲ Buy | Grant | 11,123 | $0 | 9/9/2026 |
| James Charles Theofilos | ▲ Buy | Grant | 11,123 | $0 | 9/9/2026 |
| Patricia Wilber | ▲ Buy | Grant | 11,123 | $0 | 9/9/2026 |
| Elena Bonfiglioli | ▲ Buy | Grant | 11,123 | $0 | 9/9/2026 |
| Michael Fox | ▲ Buy | Grant | 55,000 | $0 | 9/8/2026 |
| Joshua S. Lev | ▲ Buy | Grant | 55,000 | $0 | 9/8/2026 |
| Joshua S. Lev | ▲ Buy | Option Exercise | 3,000 | $14K | 8/25/2026 |
| Joshua S. Lev | ▼ Sell | Open Market | 3,000 | $28K | 8/25/2026 |
| Joshua S. Lev | ▼ Sell | Open Market | 5,000 | $49K | 8/24/2026 |
| Joshua S. Lev | ▲ Buy | Option Exercise | 5,000 | $23K | 8/24/2026 |
| Joshua S. Lev | ▲ Buy | Option Exercise | 12,000 | $54K | 8/21/2026 |
| Joshua S. Lev | ▼ Sell | Open Market | 12,000 | $123K | 8/21/2026 |
| Thomas J. Errico | ▲ Buy | Open Market | 5,000 | $49K | 8/13/2026 |
| Joshua S. Lev | ▼ Sell | Open Market | 6,667 | $60K | 5/28/2026 |
| Joshua S. Lev | ▼ Sell | Open Market | 3,000 | $20K | 5/22/2026 |
| Thomas J. Errico | ▲ Buy | Open Market | 9,992 | $60K | 5/21/2026 |
| Thomas J. Errico | ▼ Sell | Other | 8 | $48 | 5/20/2026 |
| Daniel S. Goldberger | ▼ Sell | Open Market | 80,000 | $544K | 4/23/2026 |
| Michael Fox | ▲ Buy | Grant | 70,000 | $0 | 4/13/2026 |
| Daniel S. Goldberger | ▼ Sell | Open Market | 16,072 | $97K | 4/10/2026 |
| Joshua S. Lev | ▲ Buy | Grant | 45,000 | $0 | 4/1/2026 |
| Thomas J. Errico | ▼ Sell | Other | 22,803 | $99K | 3/19/2026 |
| Thomas J. Errico | ▼ Sell | Other | 19,252 | $124K | 3/19/2026 |
| Joshua S. Lev | ▲ Buy | Grant | 2,889 | $0 | 1/26/2026 |
| Joshua S. Lev | ▲ Buy | Grant | 25,000 | $0 | 1/26/2026 |
| Daniel S. Goldberger | ▲ Buy | Grant | 20,375 | $152K | 1/26/2026 |
| Daniel S. Goldberger | ▲ Buy | Grant | 26,000 | $0 | 1/26/2026 |
| Joshua S. Lev | ▼ Sell | Open Market | 2,500 | $13K | 12/4/2025 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 1,000 | $5K | 12/2/2025 |
| Joshua S. Lev | ▼ Sell | Open Market | 2,166 | $13K | 11/12/2025 |
| Elena Bonfiglioli | ▲ Buy | Grant | 30,549 | $0 | 9/10/2025 |
| Patricia Wilber | ▲ Buy | Grant | 19,011 | $0 | 9/2/2025 |
| Julie Ann Goldstein | ▲ Buy | Grant | 19,011 | $0 | 9/2/2025 |
| Thomas J. Errico | ▲ Buy | Grant | 26,615 | $0 | 9/2/2025 |
| John P. Gandolfo | ▲ Buy | Grant | 19,011 | $0 | 9/2/2025 |
| Thomas M. Patton | ▲ Buy | Grant | 19,011 | $0 | 9/2/2025 |
| Thomas J. Errico | ▲ Buy | Open Market | 15,000 | $67K | 8/11/2025 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 1,000 | $4K | 8/11/2025 |
| James Charles Theofilos | ▲ Buy | Grant | 22,156 | $0 | 8/1/2025 |
| John P. Gandolfo | ▲ Buy | Open Market | 1,800 | $9K | 5/23/2025 |
| Thomas J. Errico | ▲ Buy | Open Market | 10,000 | $48K | 5/12/2025 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 1,000 | $9K | 3/17/2025 |
| Thomas J. Errico | ▲ Buy | Open Market | 6,000 | $49K | 3/17/2025 |
| Daniel S. Goldberger | ▲ Buy | Grant | 40,000 | $0 | 1/18/2025 |
| Joshua S. Lev | ▲ Buy | Grant | 10,000 | $0 | 1/15/2025 |
| Thomas J. Errico | ▲ Buy | Grant | 16,583 | $0 | 9/3/2024 |
| Patricia Wilber | ▲ Buy | Grant | 16,583 | $0 | 9/3/2024 |
| John P. Gandolfo | ▲ Buy | Grant | 16,583 | $0 | 9/3/2024 |
| Thomas M. Patton | ▲ Buy | Grant | 16,583 | $0 | 9/3/2024 |
| Charles Steve Theofilos | ▲ Buy | Grant | 16,582 | $0 | 9/3/2024 |
| Thomas J. Errico | ▲ Buy | Open Market | 5,000 | $31K | 8/15/2024 |
| John P. Gandolfo | ▲ Buy | Open Market | 1,000 | $6K | 6/13/2024 |
| Patricia Wilber | ▲ Buy | Grant | 6,931 | $45K | 6/5/2024 |
| Thomas J. Errico | ▲ Buy | Grant | 38,505 | $248K | 6/5/2024 |
| Julie Ann Goldstein | ▲ Buy | Grant | 7,701 | $50K | 6/5/2024 |
| Thomas M. Patton | ▲ Buy | Grant | 7,701 | $50K | 6/5/2024 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 38,505 | $248K | 6/5/2024 |
| Daniel S. Goldberger | ▲ Buy | Grant | 75,000 | $0 | 1/16/2024 |
| Brian M. Posner | ▲ Buy | Open Market | 16,000 | $0 | 1/12/2024 |
| Charles Steve Theofilos | ▲ Buy | Grant | 25,210 | $0 | 1/1/2024 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 1,500 | $8K | 9/15/2023 |
| Thomas J. Errico | ▲ Buy | Grant | 21,739 | $0 | 8/4/2023 |
| Thomas M. Patton | ▲ Buy | Grant | 21,739 | $0 | 8/4/2023 |
| John P. Gandolfo | ▲ Buy | Grant | 21,739 | $0 | 8/4/2023 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 50,000 | $0 | 8/4/2023 |
| Patricia Wilber | ▲ Buy | Grant | 21,739 | $0 | 8/2/2023 |
| Moody Trevor J | ▲ Buy | Grant | 22,662 | $99K | 8/2/2023 |
| Julie Ann Goldstein | ▲ Buy | Grant | 33,994 | $148K | 8/2/2023 |
| CUNEO F PETER | ▲ Buy | Grant | 5,665 | $25K | 8/2/2023 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 50,991 | $222K | 8/2/2023 |
| Thomas J. Errico | ▲ Buy | Grant | 45,607 | $198K | 8/2/2023 |
| Thomas M. Patton | ▲ Buy | Grant | 11,049 | $48K | 8/2/2023 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 500 | $2K | 3/17/2023 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 500 | $2K | 3/16/2023 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 500 | $2K | 3/15/2023 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 500 | $2K | 3/14/2023 |
| Thomas J. Errico | ▲ Buy | Grant | 6,750 | $24K | 3/13/2023 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 500 | $2K | 3/13/2023 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 5,000 | $2K | 12/14/2022 |
| Errico Joseph P | ▲ Buy | Open Market | 100,000 | $33K | 12/13/2022 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 5,000 | $2K | 12/13/2022 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 5,000 | $2K | 12/12/2022 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 5,000 | $1K | 12/9/2022 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 10,000 | $3K | 12/8/2022 |
| Thomas J. Errico | ▲ Buy | Grant | 205,987 | $0 | 12/2/2022 |
| Errico Joseph P | ▲ Buy | Grant | 205,987 | $0 | 12/2/2022 |
| Thomas M. Patton | ▲ Buy | Grant | 205,987 | $0 | 12/2/2022 |
| John P. Gandolfo | ▲ Buy | Grant | 205,987 | $0 | 12/2/2022 |
| Moody Trevor J | ▲ Buy | Grant | 205,987 | $0 | 12/2/2022 |
| Errico Joseph P | ▲ Buy | Open Market | 25,000 | $8K | 11/29/2022 |
| Errico Joseph P | ▲ Buy | Open Market | 50,000 | $16K | 11/25/2022 |
| Errico Joseph P | ▲ Buy | Open Market | 100,000 | $31K | 11/23/2022 |
| Errico Joseph P | ▲ Buy | Open Market | 75,000 | $25K | 11/22/2022 |
| Errico Joseph P | ▲ Buy | Open Market | 100,000 | $31K | 11/17/2022 |
| Errico Joseph P | ▲ Buy | Open Market | 100,000 | $29K | 11/16/2022 |
| Errico Joseph P | ▲ Buy | Open Market | 100,000 | $24K | 11/14/2022 |
| Errico Joseph P | ▲ Buy | Open Market | 100,000 | $24K | 11/10/2022 |
| Thomas J. Errico | ▲ Buy | Open Market | 100,000 | $22K | 11/8/2022 |
| Errico Joseph P | ▲ Buy | Open Market | 100,000 | $56K | 6/13/2022 |
| Moody Trevor J | ▲ Buy | Open Market | 39,478 | $17K | 5/31/2022 |
| Moody Trevor J | ▲ Buy | Open Market | 10,522 | $5K | 5/27/2022 |
| Julie Ann Goldstein | ▲ Buy | Grant | 100,000 | $40K | 5/23/2022 |
| Thomas J. Errico | ▲ Buy | Open Market | 15,197 | $6K | 5/19/2022 |
| Thomas J. Errico | ▲ Buy | Open Market | 42,032 | $17K | 5/18/2022 |
| Thomas J. Errico | ▲ Buy | Open Market | 42,771 | $17K | 5/17/2022 |
| John P. Gandolfo | ▲ Buy | Open Market | 15,000 | $5K | 5/17/2022 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 28,208 | $10K | 5/16/2022 |
| Patricia Wilber | ▲ Buy | Grant | 150,000 | $0 | 3/15/2022 |
| Julie Ann Goldstein | ▲ Buy | Grant | 150,000 | $0 | 3/15/2022 |
| Brian M. Posner | ▲ Buy | Open Market | 10,000 | $8K | 12/10/2021 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 15,000 | $11K | 12/7/2021 |
| Daniel S. Goldberger | ▲ Buy | Open Market | 15,000 | $11K | 11/23/2021 |
| Brian M. Posner | ▲ Buy | Open Market | 10,000 | $10K | 11/9/2021 |
| Daniel S. Goldberger | ▲ Buy | Option Exercise | 53,764 | $0 | 10/1/2021 |
| Thomas J. Errico | ▲ Buy | Grant | 707 | $19K | 8/19/2019 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
ECOR Approaches Cash Breakeven, According to SeekingAlpha
SeekingAlpha reports that electroCore is now on a trajectory toward cash breakeven. The analysis suggests the company’s operating cash flow is improving, which could reduce financial risk. This development may influence how investors view the firm’s near‑term financial stability.
ECOR Approaches Cash Breakeven, According to SeekingAlpha. SeekingAlpha reports that electroCore is now on a trajectory toward cash breakeven. The analysis suggests the company’s operating cash flow is improving, which could reduce financial risk. This development may influence how investors view the firm’s near‑term financial stability.